Emerging trends at the interface of chemistry and biology: Applications to the design of human therapeutics
Journal of Chemical Sciences, ISSN: 0973-7103, Vol: 122, Issue: 2, Page: 97-107
2010
- 17Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Captures17
- Readers17
- 17
Review Description
This article describes recent developments in the design and implementation of various strategies towards the development of novel therapeutics using first principles from biology and chemistry. Strategies for multi-target therapeutics and network analysis with a focus on cancer and HIV are discussed. Methods for gene and siRNA delivery are presented along with challenges and opportunities for siRNA therapeutics. Advances in protein design methodology and screening are described, with a focus on their application to the design of antibody based therapeutics. Future advances in this area relevant to vaccine design are also mentioned. © Indian Academy of Sciences.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=77950236533&origin=inward; http://dx.doi.org/10.1007/s12039-010-0034-7; http://link.springer.com/10.1007/s12039-010-0034-7; http://link.springer.com/content/pdf/10.1007/s12039-010-0034-7; http://link.springer.com/content/pdf/10.1007/s12039-010-0034-7.pdf; http://link.springer.com/article/10.1007/s12039-010-0034-7/fulltext.html; http://www.springerlink.com/index/10.1007/s12039-010-0034-7; http://www.springerlink.com/index/pdf/10.1007/s12039-010-0034-7; https://dx.doi.org/10.1007/s12039-010-0034-7; https://link.springer.com/article/10.1007/s12039-010-0034-7
Springer Science and Business Media LLC
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know